Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?

We read with great interest the article by M. Pons and colleagues in which they estimated the incidence of liver-related events and predictive ability of non-invasive markers of liver fibrosis after successful antiviral therapy for HCV infection.1 In this prospective 2 center study from Spain, including patients with HCV-related compensated advanced chronic liver disease (liver stiffness (LS) ≥10 kPa), hepatocellular carcinoma (HCC) developed in 4.4% (25/572) of cases within 2.8 years of the end of treatment (EOT).
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research